Summary
In patients with liver cirrhosis, especially in the advanced stage, the coexistence of low clotting factor levels, hypofibrinogenemia, thrombocytopenia and elevated fibrin(ogen) degradation product (FDP) and D-dimer levels may suggest the presence of disseminated intravascular coagulation (DIC). In this study we evaluated, in 21 patients with decompensated liver cirrhosis and elevated FDP and D-dimer levels, the time sequence of their coagulation data during a follow-up period of 15 days after the first observation; our aim was to clarify if these patients tend to develop during this time interval a severe consumption coagulopathy as an expression of overt DIC. We evaluated serum fibrinogen, platelet count, prothrombin activity, serum FDP and plasma D-dimer levels at days 1, 3, 6, 10 and 15. The coagulation data were fairly stable during the study period in all patients, even in the two patients who had upper digestive tract bleeding during the study time. Only two patients affected by infectious diseases showed a decrease of D-dimer and FDP levels after healing. Our data suggest that in decompensated liver cirrhosis the detection of elevated FDP and D-dimer levels is seldom related to the occurrence of an overt DIC, at least during a short time interval: in this condition heparin therapy seems therefore not advisable and even potentially dangerous.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bloom A. L.: Intravascular coagulation and the liver — Brit. J. Haematol.30, 1, 1975.
Carr J.: Disseminated intravascular coagulation in cirrhosis — Hepatology10, 103, 1989.
Carr J., McKinney.M., McDonagh J.: Diagnosis of disseminated intravascular coagulation: role of D-dimer — Amer. J. clin. Pathol.91, 280, 1989.
Cioni G., Cristani A., Mussini G., Grandi S., Pextore R., Zeneroli M. L., Tizzaxini W., Zagni G., Ventura E.: Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients — Ital. J. Gastroenterol.22, 64, 1990.
Clauss A. von: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens — Acta haematol. (Basel)17, 237, 1957.
Colman R., Robboy S. J., Minna J. D.: Disseminated intravascular coagulation (DIG): an approach — Amer. J. Med.52, 679, 1972.
Cristani A., Cioni G., Mussini C., Pentore R., Zagni G., Ventura E.: Proposta di un metodo per la diagnosi laboratoristica di coagulazione intravascolare disseminata nella cirrosi epatica — Recenti Progr. Med.81, 322, 1990.
D’Amico G., Morabito A., Pagliaro L., Marubini E., and The Liver Study Group of ‘V. Gervello’ Hospital: Survival and prognostic indicators in compensated and decompensated cirrhosis — Dig. Dis. Sci.31, 468, 1986.
Deykin D., Cochios F., DeCamp G.: Hepatic removal of activated factor X by the perfused rat liver — Amer. J. Physiol.214, 414, 1968.
Elms M. J., Bunce I. H., Bundesen P. G.: Measurement of cross-linked fibrin degradation products. An immunoassay using monoclonal antibodies — Thrombos. Haemostas.50, 591, 1983.
Francis J., Armstrong D. J.: Acquired dysfibrinogenemia in liver disease — J. clin. Pathol.35, 667, 1982.
Garvey M. B., Black J. M.: The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle — J. clin. Pathol.25, 680, 1972.
Green G., Thomson J. M., Dymock I. W.: Abnormal fibrin polymerisation in liver disease — Brit. J. Haematol.34, 427, 1976.
Hoefs J., Barnes T., Halle P.: Imraperitoneal coagulation in chronic liver disease ascites — Dig. Dis. Sci.26, 518, 1981.
Joist J. H.: Hemostatic abnormalities in liver disease. In:Colman R. W., Hirsh J., Marder V. J. (Eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. J. B. Lippincott Co., Philadelphia, 1987; p. 861.
Lerner R. G., Rappaport S. I., Siemsen J. K.: Disappearance of I 131 after endotoxin: effects of a first and second injection — Amer. J. Physiol.214, 532, 1968.
Minna J. D., Robboy S. J., Colman R. W.: Disseminated Intravascular Coagulation in Man. C. C. Thomas, Springfield, 1974; p. 160.
Oka K., Tanaka K.: Local fibrinolysis of oesophagus and stomach as a cause of hemorrhage in liver cirrhosis — Thrombos. Res.14, 837, 1989.
Straub P. W.: Diffuse intravascular coagulation in the liver disease? — Semin. Thrombos. Hemostas.4, 29, 1977.
Van de Yater L., Carr J. M., Aroson D., McDonagh J.: Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease — Blood67, 1468, 1987.
Verstraete M., Vermylen J., Collen D.: Intravascular coagulation in the liver disease — Ann. Rev. Med.25, 445, 1974.
Wilde J. T., Kitchen S., Greaves M., Preston F. E.: A comparison of plasma D-dimer and serum fibrinogen/fibrin degradation product levels in the investigation of hypercoagulable states. In:Lowe G. D. O. (Ed.): Fibrinogen Biochemistry, Physiology and Clinical Relevance: Workshop Proceedings. Excerpta Medica, Amsterdam, 1987; p. 219.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cioni, G., Cristani, A., Tincani, E. et al. Time sequence of coagulation data in patients with decompensated liver cirrhosis and suspected disseminated intravascular coagulation. La Ricerca Clin. Lab. 21, 105–109 (1991). https://doi.org/10.1007/BF02919119
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02919119